Zhengqing Ba

State Key Laboratory Of Cardiovascular Disease, Chinese Academy Of Medical Sciences And Peking Union Medical College, No. 167 Beilishi Road, Xicheng District
Beijing, 100037, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Artificial intelligence-enhanced management system for secondary prevention of coronary heart disease: a randomized clinical trial.

Artificial intelligence-enhanced management system for secondary prevention of coronary heart disease: a randomized clinical trial.

Journal: BMC medicine
Published: February 13, 2026

CAMI-DM: Development and validation of a multi-algorithm model for in-hospital mortality risk prediction in diabetic patients with acute myocardial infarction - The China acute myocardial infarction registry.

CAMI-DM: Development and validation of a multi-algorithm model for in-hospital mortality risk prediction in diabetic patients with acute myocardial infarction - The China acute myocardial infarction registry.

Journal: PLOS digital health
Published: January 30, 2026

Effectiveness of an AI-enhanced management system for coronary heart disease (AIM-CHD): rationale and design of a single-centre, open-label, randomised, parallel-controlled trial.

Effectiveness of an AI-enhanced management system for coronary heart disease (AIM-CHD): rationale and design of a single-centre, open-label, randomised, parallel-controlled trial.

Journal: BMJ open
Published: September 15, 2025

Trends and effectiveness of digital health management in postdischarge coronary artery disease across COVID19 pandemic.

Trends and effectiveness of digital health management in postdischarge coronary artery disease across COVID19 pandemic.

Journal: NPJ digital medicine
Published: April 22, 2025

Serum Lipid Biomarkers and the Risk of Gastrointestinal Cancers in a Chinese Population: The Kailuan Prospective Study.

Serum Lipid Biomarkers and the Risk of Gastrointestinal Cancers in a Chinese Population: The Kailuan Prospective Study.

Journal: Cancer medicine
Published: May 18, 2024

Cardiovascular comorbidities and their prognostic value in small cell lung cancer patients with chemoradiotherapy.

Cardiovascular comorbidities and their prognostic value in small cell lung cancer patients with chemoradiotherapy.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: October 12, 2023

PCSK9 Inhibitor: Safe Alternative to Fill the Treatment Gap in Statin-Limited Conditions?

PCSK9 Inhibitor: Safe Alternative to Fill the Treatment Gap in Statin-Limited Conditions?

Journal: Reviews in cardiovascular medicine
Published: August 04, 2022

A Nomogram for Predicting Survival in Patients With Colorectal Cancer Incorporating Cardiovascular Comorbidities.

A Nomogram for Predicting Survival in Patients With Colorectal Cancer Incorporating Cardiovascular Comorbidities.

Journal: Frontiers in cardiovascular medicine
Published: February 14, 2022

Risk Factors for the Comorbidity of Hypertension and Renal Cell Carcinoma in the Cardio-Oncologic Era and Treatment for Tumor-Induced Hypertension.

Risk Factors for the Comorbidity of Hypertension and Renal Cell Carcinoma in the Cardio-Oncologic Era and Treatment for Tumor-Induced Hypertension.

Journal: Frontiers in cardiovascular medicine
Published: November 06, 2021

Myoferlin, a multifunctional protein in normal cells, has novel and key roles in various cancers.

Myoferlin, a multifunctional protein in normal cells, has novel and key roles in various cancers.

Journal: Journal of cellular and molecular medicine
Published: February 21, 2019
Showing 1-10 of 10

Last Updated: 09/26/2026